Clinical Trial Update: A Single-Center, Single-Arm Study of Neoadjuvant Short-Course Radiotherapy With IL-2 Followed by Sequential Immunotherapy With CAPOX Combined With PD-1 Antibody and IL-2 for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2, single-center trial investigates neoadjuvant short-course radiotherapy with interleukin-2 followed by sequential immunotherapy using CAPOX with a PD-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Interleukin-2 (interleukin-2)
• OXALIPLATIN (Oxaliplatin)
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Rectal Cancer, Advanced Solid Tumor | Phase 2 | Status: RECRUITING